231 related articles for article (PubMed ID: 20084406)
1. Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management. Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting.
Grunberg S; Clark-Snow RA; Koeller J
Support Care Cancer; 2010 Mar; 18 Suppl 1():S1-10. PubMed ID: 20084406
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
[TBL] [Abstract][Full Text] [Related]
3. Multinational Association of Supportive Cancer Care (MASCC).
Roila F;
Support Care Cancer; 2003 Apr; 11(4):260-1. PubMed ID: 12749339
[No Abstract] [Full Text] [Related]
4. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
[TBL] [Abstract][Full Text] [Related]
5. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
[TBL] [Abstract][Full Text] [Related]
6. State of the Art Antiemetic Therapy for Cancer Patients.
Lau TK; Yip CH; Yeo W
Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
[TBL] [Abstract][Full Text] [Related]
7. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
Evers C; Riess H
Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
[No Abstract] [Full Text] [Related]
8. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Bosnjak SM; Dimitrijevic J; Djordjevic F
Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J; Szántó J
Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
[TBL] [Abstract][Full Text] [Related]
10. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.
Cefalo MG; Ruggiero A; Maurizi P; Attinà G; Arlotta A; Riccardi R
J Chemother; 2009 Dec; 21(6):605-10. PubMed ID: 20071282
[TBL] [Abstract][Full Text] [Related]
12. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Olver I; Ruhlmann CH; Jahn F; Schwartzberg L; Rapoport B; Rittenberg CN; Clark-Snow R
Support Care Cancer; 2017 Jan; 25(1):297-301. PubMed ID: 27572335
[TBL] [Abstract][Full Text] [Related]
13. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
14. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
15. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting.
Cope D
Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282
[No Abstract] [Full Text] [Related]
16. Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.
Matsuda Y; Okita K; Furuhata T; Kutomi G; Yamashita K; Sato Y; Takimoto R; Hirata K
Support Care Cancer; 2015 Nov; 23(11):3331-9. PubMed ID: 26003425
[TBL] [Abstract][Full Text] [Related]
17. 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Kennedy SKF; Goodall S; Lee SF; DeAngelis C; Jocko A; Charbonneau F; Wang K; Pasetka M; Ko YJ; Wong HCY; Chan AW; Rajeswaran T; Gojsevic M; Chow E; Gralla RJ; Ng TL; Jerzak KJ
Support Care Cancer; 2024 Apr; 32(5):280. PubMed ID: 38594320
[TBL] [Abstract][Full Text] [Related]
18. [Incidence and treatment of chemotherapy-induced nausea and emesis in gastrointestinal cancer].
Lorenzen S; Spörl S; Lordick F
Z Gastroenterol; 2014 Aug; 52(8):821-30. PubMed ID: 25111723
[TBL] [Abstract][Full Text] [Related]
19. Management of nausea and vomiting caused by anticancer drugs: state of the art.
Pisters KM; Kris MG
Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
